FDA Offers Suggestions for CT Safety

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

收藏

页码：13N / 13N

页数：1

相关论文

共 50 条

[31] Safety Terminology: Deficiencies and Suggestions
Alpeev, A. S.
ATOMIC ENERGY, 2019, 126 (05) : 339 - 341
[32] PHARMACEUTICALS FDA offers guidance for updating generic drug labels
Hess, Glenn
CHEMICAL & ENGINEERING NEWS, 2016, 94 (29) : 17 - 17
[33] FDA white paper offers solution to therapy pipeline problem
Rustgi, AK
GASTROENTEROLOGY, 2004, 126 (07) : 1652 - 1652
[34] The FDA Safety and Innovation Act
Steinbrook, Robert
Sharfstein, Joshua M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (14): : 1437 - 1438
[35] FDA and Postapproval Drug Safety
不详
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 25N - 25N
[36] FDA REAFFIRMS BISPHENOL A SAFETY
不详
CHEMICAL & ENGINEERING NEWS, 2014, 92 (50) : 19 - 19
[37] The FDA and the safety of medical products
Woodcock, J
HEALTH AFFAIRS, 2005, 24 (05) : 1377 - 1377
[38] The FDA, Preemption, and Public Safety
Gostin, Lawrence O.
HASTINGS CENTER REPORT, 2011, 41 (05) : 11 - 12
[39] FDA reviews safety of somatropin
Reactions Weekly, 2011, 1334 (1) : 2 - 2
[40] FDA shifts on bisphenol A safety
Renner, Rebecca
CHEMISTRY WORLD, 2010, 7 (03): : 13 - 13

← 1 2 3 4 5 →